Skip to main content
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc — Investor Relations & Filings

Ticker · MREO ISIN · GB00BZ4G2K23 LEI · 213800U8JQHIJOS5AS09 US Manufacturing
Filings indexed 631 across all filing types
Latest filing 2026-04-09 Annual Report
Country GB United Kingdom
Listing US MREO

About Mereo BioPharma Group plc

https://www.mereobiopharma.com/

Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases with limited or no treatment options. The company's strategy involves acquiring and advancing promising clinical-stage product candidates that have been de-prioritized by larger pharmaceutical or biotechnology companies. This capital-efficient model allows it to develop a specialized pipeline. Its two lead programs are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for Alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). Mereo BioPharma also engages in strategic partnerships and out-licenses other clinical assets to deliver impactful treatments to patients.

Recent filings

Filing Released Lang Actions
ARS - Mereo BioPharma Group plc (0001719714) (Filer)
Annual Report
2026-04-09 English
DEF 14A - Mereo BioPharma Group plc (0001719714) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English
PRE 14A - Mereo BioPharma Group plc (0001719714) (Filer)
Regulatory Filings
2026-03-27 English
8-K - Mereo BioPharma Group plc (0001719714) (Filer)
Regulatory Filings
2026-03-27 English
10-K - Mereo BioPharma Group plc (0001719714) (Filer)
Annual Report FY 2025
2026-03-19 English
8-K - Mereo BioPharma Group plc (0001719714) (Filer)
Regulatory Filings
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.